CH EPL (R5)
1.0.0-ci-build - ci-build Switzerland flag

CH EPL (R5), published by Federal Office of Public Health FOPH. This guide is not an authorized publication; it is the continuous build for version 1.0.0-ci-build built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/bag-epl/bag-epl-fhir/ and changes regularly. See the Directory of published versions

Table of Contents

.. 0 Table of Contents
... 1 Home
... 2 IDMP Standard ISO 11615
... 3 Dataexport FOPH Spezialitätenliste
... 4 Abrilada
... 5 Cuprior
... 6 Entocort
... 7 Estalis
... 8 Keytruda
... 9 Paxlovid
... 10 Triogen
... 11 Profiles
... 12 Extensions
... 13 Terminology
... 14 Changelog
... 15 Artifacts Summary
.... 15.1 CH EPL Organization
.... 15.2 CH IDMP AdministrableProductDefinition
.... 15.3 CH IDMP ClinicalUseDefinition Indication
.... 15.4 CH IDMP DocumentReference
.... 15.5 CH IDMP ManufacturedItemDefinition
.... 15.6 IDMP Bundle
.... 15.7 IDMP Ingredient
.... 15.8 IDMP MedicinalProductDefinition
.... 15.9 IDMP PackagedProductDefinition
.... 15.10 IDMP RegulatedAuthorization
.... 15.11 FOPH Dossier Number
.... 15.12 GLN Identifier
.... 15.13 LOC Identifier
.... 15.14 CH - EPL Full Limitation Text
.... 15.15 CH - EPL Product Price
.... 15.16 CH - EPL Regulated Authorization Limitation
.... 15.17 CH - EPL Reimbursement SL
.... 15.18 CH - SMC Authorized Dose Form
.... 15.19 CH - Authorisation Type
.... 15.20 CH - Medicinal Product Name Type
.... 15.21 CH - Other Characteristics Type
.... 15.22 CH EPL - Gamme
.... 15.23 CH EPL - Limitation Status
.... 15.24 CH EPL - Listing Status
.... 15.25 CH EPL - Other Characteristics Packaged Item
.... 15.26 CH EPL - Price Type
.... 15.27 CH EPL - Product Type
.... 15.28 CH EPL - Reimbursement Status
.... 15.29 CH EPL - Type of Price Change
.... 15.30 CH SMC - Additional Monitoring Indicator
.... 15.31 CH SMC - Attached Document Type
.... 15.32 CH SMC - Authorisation Category
.... 15.33 CH SMC - Authorisation Status
.... 15.34 CH SMC - Authorised Pharmaceutical Dose Form
.... 15.35 CH SMC - Ingredient Role
.... 15.36 CH SMC - Legal Status of Supply
.... 15.37 CH SMC - Marketing Status
.... 15.38 CH SMC - Pediatric Use Indicator
.... 15.39 CH SMC - Special Precautions for Storage
.... 15.40 CH SMC - Substance
.... 15.41 CH SMC - TherapeuticProductcode
.... 15.42 EDQM - Combination Packaging
.... 15.43 EDQM - Combined Pharmaceutical Dose Form
.... 15.44 EDQM - Combined Term
.... 15.45 EDQM - Packaging
.... 15.46 EDQM - Pharmaceutical Dose Form
.... 15.47 EDQM - Route Of Administration
.... 15.48 EDQM - Unit of Presentation
.... 15.49 EMA - Domain
.... 15.50 EMA - Intended Effect
.... 15.51 EMA - Shelf Life Type
.... 15.52 CH - Authorisation Type
.... 15.53 CH - Medicinal Product Name Type
.... 15.54 CH - Other Characteristics Type
.... 15.55 CH EPL - Gamme
.... 15.56 CH EPL - Limitation Status
.... 15.57 CH EPL - Listing Status
.... 15.58 CH EPL - Other Characteristics Packaged Item
.... 15.59 CH EPL - Price Type
.... 15.60 CH EPL - Product Type
.... 15.61 CH EPL - Reimbursement Status
.... 15.62 CH EPL - Type of Price Change
.... 15.63 CH SMC - Additional Monitoring Indicator
.... 15.64 CH SMC - Attached Document Type
.... 15.65 CH SMC - Authorisation Category
.... 15.66 CH SMC - Authorisation Status
.... 15.67 CH SMC - Ingredient Role
.... 15.68 CH SMC - Legal Status of Supply
.... 15.69 CH SMC - Marketing Status
.... 15.70 CH SMC - Pediatric Use Indicator
.... 15.71 CH SMC - Special Precautions for Storage
.... 15.72 CH SMC - Substance
.... 15.73 CH SMC - TherapeuticProductcode
.... 15.74 EDQM - Standard Terms
.... 15.75 EMA - Domain
.... 15.76 EMA - Intended Effect
.... 15.77 EMA - Shelf Life Type
.... 15.78 Application / Assessment Tracking Number
.... 15.79 Clinical Product Identifier
.... 15.80 FOPH Dossier Number
.... 15.81 GLN Identifier
.... 15.82 Global Trade Item Number
.... 15.83 LOC Identifier
.... 15.84 Marketing Authorisation Number
.... 15.85 Medical Product Identifier
.... 15.86 Pharmaceutical Product Identifier
.... 15.87 5204201
.... 15.88 52042011
.... 15.89 5470402
.... 15.90 54704089
.... 15.91 66231001
.... 15.92 6623101
.... 15.93 67431001
.... 15.94 6743101
.... 15.95 67719001
.... 15.96 6771901
.... 15.97 67831001
.... 15.98 67831001
.... 15.99 6783101
.... 15.100 68793001
.... 15.101 6879301
.... 15.102 ABRILADA Inj Lös 40 mg/0.8ml Fertpen 0.8 ml (Bundle)
.... 15.103 Abrilada, Injektionslösung
.... 15.104 Abrilada, Injektionslösung Fachinformation
.... 15.105 Abrilada, Injektionslösung Fachinformation
.... 15.106 CH-52042011
.... 15.107 CH-54704089
.... 15.108 CH-66231001
.... 15.109 CH-67431001
.... 15.110 CH-67831001
.... 15.111 CH-67831002
.... 15.112 CH-68291001
.... 15.113 CH-68793001
.... 15.114 CUPRIOR Filmtabl 150 mg (Bundle)
.... 15.115 CUPRIOR Filmtabl 150 mg 72 Stk
.... 15.116 Cuprior, Filmtabletten Fachinformation
.... 15.117 Cuprior, Filmtabletten Patienteninformation
.... 15.118 ENTOCORT Enema Klistier Lösung + Tabletten 7 Stk
.... 15.119 ENTOCORT Enema Klistier Lösung + Tabletten 7 Stk (Bundle)
.... 15.120 ENTOCORT Enema Klistier Lösung + Tabletten 7 Stk Fachinformation
.... 15.121 ENTOCORT Enema Klistier Lösung + Tabletten 7 Stk Patienteninformation
.... 15.122 ESTALIS Matrixpfl 50/250 24 Stk
.... 15.123 ESTALIS Matrixpfl 50/250 24 Stk (Bundle)
.... 15.124 ESTALIS Matrixpfl 50/250 24 Stk Fachinformation
.... 15.125 ESTALIS Matrixpfl 50/250 24 Stk Patienteninformation
.... 15.126 Indication 10002556
.... 15.127 Indication 10003268
.... 15.128 Indication 10009900
.... 15.129 Indication 10019927
.... 15.130 Indication 10020041
.... 15.131 Indication 10021782
.... 15.132 Indication 10027400
.... 15.133 Indication 10028881
.... 15.134 Indication 10030247
.... 15.135 Indication 10031285
.... 15.136 Indication 10037153
.... 15.137 Indication 10037160
.... 15.138 Indication 10043971
.... 15.139 Indication 10045365
.... 15.140 Indication 10046851
.... 15.141 Indication 10061091
.... 15.142 Indication 10075566
.... 15.143 Indication 10084529
.... 15.144 Indication 10089182
.... 15.145 KEYTRUDA Inf Konz 100 mg / 4 ml
.... 15.146 KEYTRUDA Inf Konz 100 mg / 4 ml (Bundle)
.... 15.147 Keytruda, Konzentrat zur Herstellung einer Infusionslösung Fachinformation
.... 15.148 Limitation 156370009
.... 15.149 Limitation 254837009
.... 15.150 Limitation 34000006
.... 15.151 Limitation 59393003
.... 15.152 Limitation 64766004
.... 15.153 Limitation 69896004
.... 15.154 Limitation 79886009
.... 15.155 Limitation 840539006
.... 15.156 Limitation 9014002
.... 15.157 Limitation 9631008
.... 15.158 MI Abrilada-40mg-Pre-Filled-Pen
.... 15.159 MI Budesonidum-2.3mg-Tablet
.... 15.160 MI Estradiol-hemihydrate-Norethisteroni-acetas-Transdermal-patch
.... 15.161 MI Nirmatrelvir-150mg-Tablet
.... 15.162 MI Pembrolizumab-100mg-Vial
.... 15.163 MI Ritonavirum-100mg-Tablet
.... 15.164 MI Solvent
.... 15.165 MI Trientinum-150mg-Tablet
.... 15.166 MI Trientinum-250mg-Capsule
.... 15.167 PAXLOVID Filmtabl 4x150mg/2x100mg
.... 15.168 PAXLOVID Filmtabl 4x150mg/2x100mg (Bundle)
.... 15.169 Paxlovid, Filmtabletten Patienteninformation
.... 15.170 PhP Abrilada-40mg-Pre-Filled-Pen
.... 15.171 PhP Budesonidum-Suspension
.... 15.172 PhP Estradiol-hemihydrate and Norethisteroni-acetas Transdermal-patch
.... 15.173 PhP Pembrolizumab-100mg-Vial
.... 15.174 PhP Trientinum-150mg-Tablet
.... 15.175 PhP Trientinum-150mg-Tablet
.... 15.176 PhP-Nirmatrelvir-150mg-Filmcoatedtablet
.... 15.177 PhP-Ritonavirum-100mg-Filmcoatedtablet
.... 15.178 Professional Information Paxlovid, Filmtabletten Fachinformation
.... 15.179 Reimbursement SL 17418
.... 15.180 Reimbursement SL 17973
.... 15.181 Reimbursement SL 20416
.... 15.182 Reimbursement SL 21070
.... 15.183 Reimbursement SL 21203 1 Pre-Filled Pen
.... 15.184 Reimbursement SL 21203 2 Pre-Filled Pen
.... 15.185 Reimbursement SL 21208
.... 15.186 Reimbursement SL 21529
.... 15.187 TRIOGEN Kaps 250 mg Ds 100 Stk
.... 15.188 TRIOGEN Kaps 250 mg Ds 100 Stk (Bundle)
.... 15.189 Triogen, Kapseln Fachinformation
.... 15.190 Triogen, Kapseln Patienteninformation